There are 398 resources available
Q&A
Presenter: All Speakers
Session: Emerging new drugs and strategies for breast cancer
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Treating HER2 low metastatic breast cancer
Resources:
Webcast
Introduction and first vote
Presenter: Christos Sotiriou
Session: Is molecular profiling useful for metastatic luminal breast cancer?
Resources:
Slides
Webcast
Yes
Presenter: Bora Lim
Session: Is molecular profiling useful for metastatic luminal breast cancer?
Resources:
Slides
Webcast
No
Presenter: Thomas Bachelot
Session: Is molecular profiling useful for metastatic luminal breast cancer?
Resources:
Slides
Webcast
Second vote and conclusions
Presenter: Christos Sotiriou
Session: Is molecular profiling useful for metastatic luminal breast cancer?
Resources:
Slides
Webcast
Gene-expression signature for treatment decision-making: Who to test? Which signature?
Presenter: Miguel Martin Jimenez
Session: Adjuvant treatment luminal in breast cancer
Resources:
Slides
Webcast
Implementation of new systemic therapies for advanced breast cancer in the Netherlands: Lessons learned from the SONABRE register
Presenter: Sandra Geurts
Session: Lessons from real world data
Resources:
Slides
Webcast
Neoadjuvant therapy: Endocrine therapy or chemotherapy?
Presenter: Sung-Bae Kim
Session: Adjuvant treatment luminal in breast cancer
Resources:
Slides
Webcast
LBA2 - Assessment of Ki67 and FOXC1-based response predictor tracking proliferation and plasticity as a complementary diagnostic for neoadjuvant Olaparib+Paclitaxel+Darvalumab in primary triple negative breast cancer: retrospective analysis of the I-SPY2 Trial
Presenter: Partha Ray
Session: Mini Oral session 3
Resources:
Abstract
Slides
Webcast